Pyrimidine TBK/IKKe inhibitor compounds and uses thereof
US11440899B2 · kind B2 · utility
1Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2018 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Oct 17, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.